We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ACRO, Drugmakers Seek Clearer Guidance on Multiple-Endpoint Trials
ACRO, Drugmakers Seek Clearer Guidance on Multiple-Endpoint Trials
Clinical research organizations and pharmaceutical companies are seeking greater clarity in an FDA draft guidance covering clinical trials with multiple endpoints.